The Food and Drug Administration (FDA) has cleared the Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD).

The Jewel wearable cardioverter defibrillator system can be worn during sleep and showers, with its low-profile and ...

The US Food and Drug Administration (FDA) has approved Element Science’s premarket approval application for its Jewel Patch Wearable Cardioverter Defibrillator (Patch-WCD) intended for cardiac care.

Observational studies at the SCAI meeting favored the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound) over ...

Wearable cardiac devices developer Kestra Medical Technologies has revealed plans to raise around $154m in an initial public offering (IPO). The US-based company is selling ten million common ...

Element Science receives US FDA approval for revolutionary Jewel Patch Wearable Cardioverter Defibrillator: San Francisco ...

This platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). It also includes a suite of integrated ...

Credit: Element Sciences. The system uses a proprietary algorithm to detect and classify shockable arrhythmias. The Jewel Patch-WCD is designed to be worn continuously for up to a week at a time ...

The US Food and Drug Administration (FDA) has approved Element Science’s premarket approval application for its Jewel Patch Wearable Cardioverter Defibrillator (Patch-WCD) intended for cardiac care.

About the Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD) The Jewel® Patch-WCD is a novel, water resistant wearable cardioverter defibrillator designed to detect and treat life ...

Element Science is proud to announce that its innovative Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD) has received U.S. Food and Drug Administration (FDA) approval of its ...